You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 2, August 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low Molecular Weight Dextran Therapy in Surgical Shock

Part 1. Control Group and Shock Patients Resuscitated Prior to Low Molecular Weight Dextran Therapy

ROBERT J. BAKER, MD; WILLIAM C. SHOEMAKER, MD; FUJIO SUZUKI, MD; ROBERT J. FREEARK, MD; E. LEE STROHL, MD

AMA Arch Surg. 1964;89(2):373-379.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

A wealth of information has accumulated over the past 30 years on the problems relating to shock, a great deal of which was derived from animal experimentation. Despite the tremendous value of such studies, it has long been recognized that the controlled shock of the laboratory is frequently a far cry from the clinical situation engendered by deep shock.

Laboratory and clinical observations have sought to illuminate shock problems in two spheres, namely, pathophysiologic mechanisms, and, subsequently, appropriate, effective treatment. Unfortunately, mechanisms observed in the laboratory and at the bedside did not seem consistently to be identical, and, more often, treatment did not seem to have the same, or even similar, results.

One obviously dissimilar feature between the experimental model and its human counterpart is the number of factors involved. The Wiggers preparation, encompassing controlled, graded hemorrhage and volumetric replacement in the dog, is not a clinical phenomenon. The . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the Department of Surgical Research, Division of Surgery, and the Hektoen Institute of the Cook County Hospital, and the departments of surgery of the University of Illinois College of Medicine and the Chicago Medical School.


Footnotes

Read before the 21st Annual Meeting of the Central Surgical Association, Rochester, Minn, Feb 27-29, 1964.

Supported in part by United States Public Health grant No. HE 08512, United States Public Health Career Research Award No. 1-K6-HE-6305, and by the Charles H. and Rachel M. Schwab Memorial Foundation.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.